Immunotherapy (Adoptive cell transfer)

LE WE PMID CA

Immunotherapy (Adoptive cell transfer)

12194

Immunotherapie (Adoptive Zelluebertragung)

Bone marrow transplantation

Cell tracking

Dendritic cell (Immunology)

Immune reconstitution

Immunodeficiency (Inherited)

Immunosuppressive agents

Immunotherapy (Adoptive cell transfer)

Leukemia (chronic lymphatic)

Lymphoma (BASKET)

NK cells

Prostate (Neoplasia)

Sipuleucel T

Vaccine (Oncology)

2008 1	Post-transplant adoptive T-cell immunotherapy. [18790452] Best Pract Res Clin Haematol 21(3): 503-19 (2008)
2008 2	Adoptive T-cell immunotherapy of chronic lymphocytic leukaemia. [18790444] Best Pract Res Clin Haematol 21(3): 375-89 (2008)
2010 3	T-cell therapy: the next generation. [21083454] Expert Rev Hematol 3(2): 123-5 (2010)
2010 4	Non-invasive cell tracking in cancer and cancer therapy. [20388105] Curr Top Med Chem 10(12): 1237-48 (2010)
2011 5	Sipuleucel-T in patients with metastatic castration-resistant prostate cancer: an insight for oncologists. [21789160] Ther Adv Med Oncol 3(2): 101-8 (2011)
2007 6	Adoptive cell transfer therapy. [18083376] Semin Oncol 34(6): 524-31 (2007)
2010 7	Artificial antigen-presenting cells for use in adoptive immunotherapy. [20693850] Cancer J 16(4): 374-81 (2010)
2011 8	Cytokine induced killer cells as promising immunotherapy for solid tumors. [21716717] J Cancer 2(-): 363-8 (2011)
2009 9	Expansion and activation of natural killer cells for cancer immunotherapy. [19411773] Korean J Lab Med 29(2): 89-96 (2009)
2010 10	T-cell-based therapies for malignancy and infection in childhood. [20307713] Pediatr Clin North Am 57(1): 83-96 (2010)
2009 11	Improving cellular therapy for primary immune deficiency diseases: recognition, diagnosis, and management. [20004776] J Allergy Clin Immunol 124(6): 1152-60.e12 (2009)
2011 12	Natural killer cell-based therapies. [21654924] F1000 Med Rep 3(-): 9 (2011)
2010 13	T-cell based immunotherapy in experimental autoimmune encephalomyelitis and multiple sclerosis. [20231863] Immunotherapy 2(1): 99-115 (2010)
2009 14	Chimeric T cells for adoptive immunotherapy of cancer: using what have we learned to plan for the future. [20635906] Immunotherapy 1(6): 905-12 (2009)
2010 15	Defining the probability that a cell therapy will produce a malignancy. [20596063] Mol Ther 18(7): 1249-50 (2010)
2003 16	Reprogramming immune responses: enabling cellular therapies and regenerative medicine. [12529548] Stem Cells 21(1): 21-32 (2003)
2009 17	Treatment of lymphoma with adoptively transferred T cells. [19723016] Expert Opin Biol Ther 9(11): 1407-25 (2009)
2009 18	Immunotherapy of human cancers using gene modified T lymphocytes. [19860654] Curr Gene Ther 9(5): 396-408 (2009)
2011 19	Optimization manufacture of virus- and tumor-specific T cells. [21915183] Stem Cells Int 2011(-): 434392 (2011)
2010 20	Redirecting the immune response: role of adoptive T cell therapy. [20201627] Hum Gene Ther 21(5): 533-41 (2010)
2011 21	Sipuleucel-T for therapy of asymptomatic or minimally symptomatic, castrate-refractory prostate cancer: an update and perspective among other treatments. [21792315] Onco Targets Ther 4(-): 79-96 (2011)
2011 22	Monocyte-derived DC maturation strategies and related pathways: a transcriptional view. [21258790] Cancer Immunol Immunother 60(4): 457-66 (2011)
2010 23	Dendritic cell recovery post-lymphodepletion: a potential mechanism for anti-cancer adoptive T cell therapy and vaccination. [19921513] Cancer Immunol Immunother 59(3): 341-53 (2010)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Fatal error: Uncaught Error: Call to undefined function mysql_connect() in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Immunotherapy (Adoptive cell transfer).php:92 Stack trace: #0 {main} thrown in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Immunotherapy (Adoptive cell transfer).php on line 92